巴西的放射治疗资源 (RT2030):对2030年的全面分析和预测
Arthur Accioly Rosa1, Cecília Félix Penido Mendes de Sousa2, Leonardo Cunha Furbino Pimentel3
1Grupo Oncoclínicas, Salvador, Bahia, Brazil; Latin America Cooperative Oncology Group, Porto Alegre, Brazil.
The Lancet. Oncology
|August 4, 2023
概括
巴西面临着对放射治疗的未满足需求,数据缺口阻碍了政策. 本研究概述了当前的情况和2030年的项目需求,并提出了一项行动计划,以改善癌症护理的准入.
科学领域:
- 在瘤学瘤学.
- 公共卫生政策 公共卫生政策
- 医疗保健服务研究 医疗服务研究
背景情况:
- 巴西对放射治疗的需求很大,目前还没有得到满足.
- 关于国家放射治疗网络的数据严重缺乏,阻碍了有效的政策制定.
- 这项研究解决了巴西放射治疗服务全面评估和规划的关键需求.
研究的目的:
- 评估巴西放射治疗服务的现状.
- 到2030年估计未来的放射治疗需求和资源需求.
- 制定一个可行的计划,确保所有巴西患者平等获得放射治疗.
主要方法:
- 一个由关键利益相关者组成的全国性工作组 (RT2030) 进行了这项研究.
- 数据收集包括对国家数据库进行全面搜索,并向263个放射治疗中心分发问卷.
- 对2030年需求的预测是基于癌症发病率,人口增长和已建立的放射治疗使用指南.
主要成果:
- 巴西有263个运营中的放射治疗中心,有409台治疗机器,每年为23万多名患者提供服务.
- 平均占用率为每台机器566名患者,技术可用性的区域和系统差异很大.
- 到2030年,估计有639,994例新的癌症病例将需要332,797个放射治疗课程,需要530个线性加速器 (LINAC),1079名辐射瘤学家和1060名医学物理学家.
结论:
- 预计癌症发病率的增加可能会加剧癌症护理现有的差异.
- 该研究提供了巴西放射治疗网络的重要路线图,突出了当前的挑战和未来的需求.
- 这些发现为明智的癌症政策规划奠定了基础,以提高放射治疗的获取和结果.
更多相关视频
08:25Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
Published on: April 11, 2018
15.3K
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
7.3K
相关概念视频
Radiation: Applications
1.2K
The average temperature of Earth is the subject of much current discussion. Earth is in radiative contact with both the Sun and dark space; it receives almost all its energy from the radiation of the Sun and reflects some of it into outer space. Dark space is very cold, about 3 K, so Earth radiates energy into it. For instance, heat transfer occurs from soil and grasses, the rate of which can be so rapid that frost can occur on clear summer evenings, even in warm latitudes.
The average...
The average...
1.2K
Biological Effects of Radiation
15.5K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
15.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Absorption of Radiation
762
The rate of heat transfer by emitted radiation is described by the Stefan-Boltzmann law of radiation:
762
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
